Third Rock Ventures Lp - Net Worth and Insider Trading

Third Rock Ventures Lp Net Worth

The estimated net worth of Third Rock Ventures Lp is at least $249 Million dollars as of 2024-04-27. Third Rock Ventures Lp is the 10% Owner of Foundation Medicine Inc and owns about 950,956 shares of Foundation Medicine Inc (FMI) stock worth over $130 Million. Third Rock Ventures Lp is the 10% Owner of Constellation Pharmaceuticals Inc and owns about 2,983,051 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $101 Million. Third Rock Ventures Lp is also the 10% Owner of Agios Pharmaceuticals Inc and owns about 545,454 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $17 Million. Besides these, Third Rock Ventures Lp also holds CytomX Therapeutics Inc (CTMX) . Details can be seen in Third Rock Ventures Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Third Rock Ventures Lp has not made any transactions after 2018-07-23 and currently still holds the listed stock(s).

Transaction Summary of Third Rock Ventures Lp

To

Third Rock Ventures Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Third Rock Ventures Lp owns 9 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Constellation Pharmaceuticals Inc (CNST) , and CytomX Therapeutics Inc (CTMX) among others .

Click here to see the complete history of Third Rock Ventures Lp’s form 4 insider trades.

Insider Ownership Summary of Third Rock Ventures Lp

Ticker Comapny Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2017-10-04 10 percent owner
CNST Constellation Pharmaceuticals Inc 2018-08-22 10 percent owner
CTMX CytomX Therapeutics Inc 2017-03-27 10 percent owner
LRMR Larimar Therapeutics Inc 2015-03-24 10 percent owner
FMI Foundation Medicine Inc 2015-05-14 10 percent owner
AGIO Agios Pharmaceuticals Inc 2014-06-24 10 percent owner
BLUE bluebird bio Inc 2013-12-16 10 percent owner
SESN Sesen Bio Inc 2014-02-11 10 percent owner
CARM CARISMA Therapeutics Inc 2014-02-11 10 percent owner

Third Rock Ventures Lp Latest Holdings Summary

Third Rock Ventures Lp currently owns a total of 4 stocks. Among these stocks, Third Rock Ventures Lp owns 950,956 shares of Foundation Medicine Inc (FMI) as of April 7, 2015, with a value of $130 Million and a weighting of 52.33%. Third Rock Ventures Lp owns 2,983,051 shares of Constellation Pharmaceuticals Inc (CNST) as of July 23, 2018, with a value of $101 Million and a weighting of 40.73%. Third Rock Ventures Lp also owns 545,454 shares of Agios Pharmaceuticals Inc (AGIO) as of July 23, 2013, with a value of $17 Million and a weighting of 6.9%. The other 1 stocks CytomX Therapeutics Inc (CTMX) have a combined weighting of 0.04% among all his current holdings.

Latest Holdings of Third Rock Ventures Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FMI Foundation Medicine Inc 2015-04-07 950,956 137.00 130,280,972
CNST Constellation Pharmaceuticals Inc 2018-07-23 2,983,051 33.99 101,393,903
AGIO Agios Pharmaceuticals Inc 2013-07-23 545,454 31.49 17,176,346
CTMX CytomX Therapeutics Inc 2017-03-27 59,777 1.59 95,045

Holding Weightings of Third Rock Ventures Lp


Third Rock Ventures Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 3,976,278 shares on April 7, 2015, which brought Third Rock Ventures Lp around $199 Million.

According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years. The most-recent trade in Constellation Pharmaceuticals Inc is the acquisition of 266,667 shares on July 23, 2018, which cost Third Rock Ventures Lp around $4 Million.

According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 0 shares on July 23, 2013, which brought Third Rock Ventures Lp around $0.

More details on Third Rock Ventures Lp's insider transactions can be found in the Insider Trading History of Third Rock Ventures Lp table.

Insider Trading History of Third Rock Ventures Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Third Rock Ventures Lp Trading Performance

GuruFocus tracks the stock performance after each of Third Rock Ventures Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Third Rock Ventures Lp is -42.73%. GuruFocus also compares Third Rock Ventures Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Third Rock Ventures Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Third Rock Ventures Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Third Rock Ventures Lp

Average Return

-17.58%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.31 -42.73 -45.95 -17.58 56.68 43.89
Relative Return to S&P 500(%) -13.09 -40.37 -39.95 -24.65 49.33 27.64

Third Rock Ventures Lp Ownership Network

Ownership Network List of Third Rock Ventures Lp

No Data

Ownership Network Relation of Third Rock Ventures Lp


Third Rock Ventures Lp Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Third Rock Ventures Lp is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Technical Officer Joseph Shulman , and EVP & Head of North America Jennifer Chien .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Third Rock Ventures Lp made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 252,926 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 252,926 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Third Rock Ventures Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Third Rock Ventures Lp. You might contact Third Rock Ventures Lp via mailing address: 29 Newbury Street, Suite 401, Boston Ma 02116.

Discussions on Third Rock Ventures Lp

No discussions yet.